Pyxis Oncology Inc. (PYXS)

1.20

0.07 (6.19%)

At close: Feb 28, 2025, 3:59 PM

1.18

-1.67%

Pre-market: Mar 03, 2025, 04:11 AM EST

Pyxis Oncology Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-73.79M	-120.72M	-75.97M	-12.83M	-2.77M
Depreciation & Amortization	1.93M	709K	647K	469K	n/a
Stock-Based Compensation	16.95M	15.76M	6.44M	44K	28K
Other Working Capital	-8.16M	12.83M	2.03M	1.73M	213K
Other Non-Cash Items	-4.13M	10.41M	20.6M	-56K	-264K
Deferred Income Tax	n/a	n/a	6.28M	n/a	n/a
Change in Working Capital	-11.66M	4.5M	6.68M	2.29M	505K
Operating Cash Flow	-70.71M	-89.33M	-35.33M	-10.08M	-2.24M
Capital Expenditures	-6.73M	-6.4M	-540K	-1.48M	n/a
Acquisitions	6.66M	n/a	-50K	n/a	n/a
Purchase of Investments	-196.83M	n/a	-50K	n/a	n/a
Sales Maturities Of Investments	92.05M	n/a	50.05K	n/a	n/a
Other Investing Acitivies	n/a	n/a	-50	n/a	n/a
Investing Cash Flow	-104.85M	-6.4M	-590K	-1.48M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-193K	183K	151.75M	32K	43.9M
Financial Cash Flow	5.93M	183K	304.04M	35K	21.95M
Net Cash Flow	-169.63M	-95.55M	268.13M	-11.53M	19.72M
Free Cash Flow	-77.44M	-95.73M	-35.87M	-11.57M	-2.24M